Cargando…

A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes

BACKGROUND: The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A composite that captures information from both may provide a simpler way of assessing risk. METHODS: 9115 of 9901 Researching Cardiovascular Events w...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerstein, Hertzel C., Ramasundarahettige, Chinthanie, Avezum, Alvero, Basile, Jan, Conget, Ignacio, Cushman, William C., Dagenais, Gilles R., Franek, Edward, Lakshmanan, Mark, Lanas, Fernando, Leiter, Lawrence A., Pogosova, Nana, Probstfield, Jeffrey, Raubenheimer, Peter J., Riddle, Matthew, Shaw, Jonathan, Sheu, Wayne H.-H., Temelkova-Kurktschiev, Theodora, Turfanda, Ibrahim, Xavier, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396793/
https://www.ncbi.nlm.nih.gov/pubmed/35996147
http://dx.doi.org/10.1186/s12933-022-01594-6
_version_ 1784771998871715840
author Gerstein, Hertzel C.
Ramasundarahettige, Chinthanie
Avezum, Alvero
Basile, Jan
Conget, Ignacio
Cushman, William C.
Dagenais, Gilles R.
Franek, Edward
Lakshmanan, Mark
Lanas, Fernando
Leiter, Lawrence A.
Pogosova, Nana
Probstfield, Jeffrey
Raubenheimer, Peter J.
Riddle, Matthew
Shaw, Jonathan
Sheu, Wayne H.-H.
Temelkova-Kurktschiev, Theodora
Turfanda, Ibrahim
Xavier, Denis
author_facet Gerstein, Hertzel C.
Ramasundarahettige, Chinthanie
Avezum, Alvero
Basile, Jan
Conget, Ignacio
Cushman, William C.
Dagenais, Gilles R.
Franek, Edward
Lakshmanan, Mark
Lanas, Fernando
Leiter, Lawrence A.
Pogosova, Nana
Probstfield, Jeffrey
Raubenheimer, Peter J.
Riddle, Matthew
Shaw, Jonathan
Sheu, Wayne H.-H.
Temelkova-Kurktschiev, Theodora
Turfanda, Ibrahim
Xavier, Denis
author_sort Gerstein, Hertzel C.
collection PubMed
description BACKGROUND: The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A composite that captures information from both may provide a simpler way of assessing risk. METHODS: 9115 of 9901 Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) participants with both an ACR and eGFR at baseline were included in this post hoc epidemiologic analysis. The hazard of higher baseline levels of 1/eGFR and natural log transformed ACR (calculated as ln [ACR × 100] to eliminate negative values) and their interaction for incident major adverse cardiovascular events (MACE), kidney outcomes, and deaths was estimated. The hazard of the geometric mean of these two baseline measures (the kidney disease index or KDI) was also assessed. RESULTS: A non-linear relationship was observed between 1/eGFR and all three outcomes, and between ln [ACR × 100] and the kidney outcome. There was also a negative interaction between these two risk factors with respect to MACE and death. Conversely, a linear relationship was noted between the KDI and all three outcomes. People in the highest KDI fifth experienced the highest incidence of MACE, death, and the kidney outcome (4.43, 4.56, and 5.55/100 person-years respectively). C statistics for the KDI were similar to those for eGFR and albuminuria. CONCLUSIONS: The KDI combines the baseline eGFR and ACR into a novel composite risk factor that has a simple linear relationship with incident serious outcomes in people with diabetes and additional CV risk factors. Trial Registration clinicaltrials.gov NCT01394952. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01594-6.
format Online
Article
Text
id pubmed-9396793
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93967932022-08-24 A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes Gerstein, Hertzel C. Ramasundarahettige, Chinthanie Avezum, Alvero Basile, Jan Conget, Ignacio Cushman, William C. Dagenais, Gilles R. Franek, Edward Lakshmanan, Mark Lanas, Fernando Leiter, Lawrence A. Pogosova, Nana Probstfield, Jeffrey Raubenheimer, Peter J. Riddle, Matthew Shaw, Jonathan Sheu, Wayne H.-H. Temelkova-Kurktschiev, Theodora Turfanda, Ibrahim Xavier, Denis Cardiovasc Diabetol Research BACKGROUND: The estimated glomerular filtration rate (eGFR) and the albumin-to-creatinine ratio (ACR) are risk factors for diabetes-related outcomes. A composite that captures information from both may provide a simpler way of assessing risk. METHODS: 9115 of 9901 Researching Cardiovascular Events with a Weekly Incretin in Diabetes (REWIND) participants with both an ACR and eGFR at baseline were included in this post hoc epidemiologic analysis. The hazard of higher baseline levels of 1/eGFR and natural log transformed ACR (calculated as ln [ACR × 100] to eliminate negative values) and their interaction for incident major adverse cardiovascular events (MACE), kidney outcomes, and deaths was estimated. The hazard of the geometric mean of these two baseline measures (the kidney disease index or KDI) was also assessed. RESULTS: A non-linear relationship was observed between 1/eGFR and all three outcomes, and between ln [ACR × 100] and the kidney outcome. There was also a negative interaction between these two risk factors with respect to MACE and death. Conversely, a linear relationship was noted between the KDI and all three outcomes. People in the highest KDI fifth experienced the highest incidence of MACE, death, and the kidney outcome (4.43, 4.56, and 5.55/100 person-years respectively). C statistics for the KDI were similar to those for eGFR and albuminuria. CONCLUSIONS: The KDI combines the baseline eGFR and ACR into a novel composite risk factor that has a simple linear relationship with incident serious outcomes in people with diabetes and additional CV risk factors. Trial Registration clinicaltrials.gov NCT01394952. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01594-6. BioMed Central 2022-08-22 /pmc/articles/PMC9396793/ /pubmed/35996147 http://dx.doi.org/10.1186/s12933-022-01594-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gerstein, Hertzel C.
Ramasundarahettige, Chinthanie
Avezum, Alvero
Basile, Jan
Conget, Ignacio
Cushman, William C.
Dagenais, Gilles R.
Franek, Edward
Lakshmanan, Mark
Lanas, Fernando
Leiter, Lawrence A.
Pogosova, Nana
Probstfield, Jeffrey
Raubenheimer, Peter J.
Riddle, Matthew
Shaw, Jonathan
Sheu, Wayne H.-H.
Temelkova-Kurktschiev, Theodora
Turfanda, Ibrahim
Xavier, Denis
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
title A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
title_full A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
title_fullStr A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
title_full_unstemmed A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
title_short A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
title_sort novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396793/
https://www.ncbi.nlm.nih.gov/pubmed/35996147
http://dx.doi.org/10.1186/s12933-022-01594-6
work_keys_str_mv AT gersteinhertzelc anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT ramasundarahettigechinthanie anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT avezumalvero anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT basilejan anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT congetignacio anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT cushmanwilliamc anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT dagenaisgillesr anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT franekedward anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT lakshmananmark anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT lanasfernando anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT leiterlawrencea anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT pogosovanana anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT probstfieldjeffrey anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT raubenheimerpeterj anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT riddlematthew anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT shawjonathan anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT sheuwaynehh anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT temelkovakurktschievtheodora anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT turfandaibrahim anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT xavierdenis anovelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT gersteinhertzelc novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT ramasundarahettigechinthanie novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT avezumalvero novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT basilejan novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT congetignacio novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT cushmanwilliamc novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT dagenaisgillesr novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT franekedward novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT lakshmananmark novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT lanasfernando novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT leiterlawrencea novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT pogosovanana novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT probstfieldjeffrey novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT raubenheimerpeterj novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT riddlematthew novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT shawjonathan novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT sheuwaynehh novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT temelkovakurktschievtheodora novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT turfandaibrahim novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes
AT xavierdenis novelkidneydiseaseindexreflectingboththealbumintocreatinineratioandestimatedglomerularfiltrationratepredictedcardiovascularandkidneyoutcomesintype2diabetes